A Study of MIRCERA in Participants With Chronic Kidney Disease Stage 3-4 and Not on Dialysis
NCT02567188 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 144
Last updated 2025-09-11
Summary
An observational, longitudinal, multi-center, non-interventional study in participants with chronic kidney disease (CKD) stage 3-4, assessed by Modification of Diet in Renal Disease (MDRD) to collect data regarding safety and efficacy in participants with pre-dialysis situation who are treated with MIRCERA in normal clinical environment.
Conditions
Interventions
- OTHER
-
MIRCERA
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Clinical Trials · Hoffmann-La Roche
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-04-30
- Primary Completion
- 2011-04-30
- Completion
- 2011-04-30
Countries
- Sweden
Study Locations
More Related Trials
-
An Observational Study to Evaluate the Effectiveness of Mircera Treatment for Renal Anemia in Pre-dialysis Participants With Chronic Kideny Disease (CKD)
NCT02547454 ·Status: COMPLETED
-
Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
NCT07119372 ·Status: RECRUITING ·Phase: PHASE3
-
A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease
NCT05951192 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Methoxy Polyethylene Glycol-epoetin Beta (Mircera) in Participants With Chronic Kidney Disease (PRIMAVERA)
NCT01194154 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) in Chronic Kidney Disease Participants on Dialysis
NCT02238080 ·Status: COMPLETED
-
Comparative Study of the Efficacy and Safety of BCD-131 and Mircera in Treatment of Anemia in CKD Patients on Dialysis
NCT03519243 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study of Hemoglobin Stability in Chronic Kidney Disease Patients on Dialysis Treated With Mircera (Methoxy Polyethylene Glycol-epoetin Beta)
NCT01974271 ·Status: COMPLETED
-
A Clinical Study of Calderasib (MK-1084) in Participants With Renal Impairment (MK-1084-010)
NCT06814119 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Efficacy and Safety of GX-E2 in the Anemic Patients Diagnosed With Chronic Kidney Disease (CKD)
NCT02044653 ·Status: COMPLETED ·Phase: PHASE2
-
Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D
NCT02492620 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Comparative, Open-label Study of IV Monofer® Administered as Maintenance Therapy by Single or Repeated Bolus Injections in Comparison With IV Iron Sucrose in Subjects With CKD-5D
NCT01222884 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis
NCT05265325 ·Status: COMPLETED ·Phase: PHASE2
-
Phase Ib Study to Evaluate PRS-080 in Anemic Chronic Kidney Disease Patients
NCT02754167 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Observational Study of Methoxy Polyethylene Glycol Epoetin Beta Daily Use in Participants on Peritoneal Dialysis
NCT02596945 ·Status: COMPLETED
-
Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease
NCT02940860 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 2a Study to Evaluate PRS-080 in Anemic Chronic Kidney Disease Patients
NCT03325621 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis
NCT02260193 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease
NCT00830037 ·Status: TERMINATED ·Phase: PHASE4
-
Renal Impairment Study of PF-06700841
NCT04260464 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety of MB-102 (Relmapirazin) and the MediBeacon Transdermal GFR Measurement System in Evaluation of Kidney Function in Normal and Renal Compromised Subjects
NCT05425719 ·Status: COMPLETED ·Phase: PHASE3
-
Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis
NCT04456803 ·Status: COMPLETED ·Phase: PHASE3
-
Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis.
NCT04925674 ·Status: COMPLETED ·Phase: PHASE1
-
Equivalence of Triferic® (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients
NCT03303144 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia
NCT04925661 ·Status: COMPLETED ·Phase: PHASE1
-
A Renal Impairment Study for PF-04965842
NCT03660241 ·Status: COMPLETED ·Phase: PHASE1